546 related articles for article (PubMed ID: 24733191)
1. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial.
Lv QW; Zhang W; Shi Q; Zheng WJ; Li X; Chen H; Wu QJ; Jiang WL; Li HB; Gong L; Wei W; Liu H; Liu AJ; Jin HT; Wang JX; Liu XM; Li ZB; Liu B; Shen M; Wang Q; Wu XN; Liang D; Yin YF; Fei YY; Su JM; Zhao LD; Jiang Y; Li J; Tang FL; Zhang FC; Lipsky PE; Zhang X
Ann Rheum Dis; 2015 Jun; 74(6):1078-86. PubMed ID: 24733191
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study.
Zhou YZ; Zhao LD; Chen H; Zhang Y; Wang DF; Huang LF; Lv QW; Liu B; Li Z; Wei W; Li H; Liao X; Liu H; Liu X; Jin H; Wang J; Fei YY; Wu QJ; Zhang W; Shi Q; Zheng WJ; Zhang FC; Tang FL; Lipsky PE; Zhang X
Arthritis Res Ther; 2018 Apr; 20(1):70. PubMed ID: 29636089
[TBL] [Abstract][Full Text] [Related]
3. Effect of cream, prepared with Tripterygium wilfordii Hook F and other four medicinals, on joint pain and swelling in patients with rheumatoid arthritis: a double-blinded, randomized, placebo controlled clinical trial.
Jiao J; Tang X; Gong X; Yin H; Jiang Q; Wei C
J Tradit Chin Med; 2019 Feb; 39(1):89-96. PubMed ID: 32186028
[TBL] [Abstract][Full Text] [Related]
4. Tripterygium wilfordii Hook F combination therapy with methotrexate for rheumatoid arthritis: An updated meta-analysis.
Luo Y; Hou X; Xi A; Luo M; Wang K; Xu Z
J Ethnopharmacol; 2023 May; 307():116211. PubMed ID: 36706936
[TBL] [Abstract][Full Text] [Related]
5. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis.
Wang X; Zu Y; Huang L; Yu J; Zhao H; Wen C; Chen Z; Xu Z
Life Sci; 2017 Feb; 171():45-50. PubMed ID: 28088452
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.
Goldbach-Mansky R; Wilson M; Fleischmann R; Olsen N; Silverfield J; Kempf P; Kivitz A; Sherrer Y; Pucino F; Csako G; Costello R; Pham TH; Snyder C; van der Heijde D; Tao X; Wesley R; Lipsky PE
Ann Intern Med; 2009 Aug; 151(4):229-40, W49-51. PubMed ID: 19687490
[TBL] [Abstract][Full Text] [Related]
7. 2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis.
Zhang X; Xia J; Jiang Y; Pisetsky DS; Smolen JS; Mu R; Dai S; Weinblatt ME; Kvien TK; Li J; Dörner T; Zhang Y; Lu L; Yang C; Yang P; Zhang Y; Xu C; Zhao Z; Lipsky PE
J Autoimmun; 2024 Jan; 142():103148. PubMed ID: 37967495
[TBL] [Abstract][Full Text] [Related]
8. Comment on: 'comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial' by Qian-wen et al.
Landewé RB; van der Heijde D
Ann Rheum Dis; 2014 Oct; 73(10):e62. PubMed ID: 25013090
[No Abstract] [Full Text] [Related]
9. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of adalimumab combined with Tripterygium wilfordii Hook F in the treatment of patient with rheumatoid arthritis: A multicenter, open-label, randomized-controlled trial.
Luo F; Gau SY; Wu YX; Liao HL; Tang F; Zhong Q; Huang Y; Hou L; Liu ZQ; Cai JL; Cao YP; Lu DM; An Y; Lan WY; Liu C; Chen CM; Jia ET; Yao XM; Wei JC; Ma WK
Int J Rheum Dis; 2024 Jan; 27(1):e15031. PubMed ID: 38287544
[TBL] [Abstract][Full Text] [Related]
11. Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial.
Jiang M; Zha Q; Zhang C; Lu C; Yan X; Zhu W; Liu W; Tu S; Hou L; Wang C; Zhang W; Liang Q; Fan B; Yu J; Zhang W; Liu X; Yang J; He X; Li L; Niu X; Liu Y; Guo H; He B; Zhang G; Bian Z; Lu A
Sci Rep; 2015 Apr; 5():9700. PubMed ID: 26814847
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis.
Cohen SB; Cheng TT; Chindalore V; Damjanov N; Burgos-Vargas R; Delora P; Zimany K; Travers H; Caulfield JP
Arthritis Rheum; 2009 Feb; 60(2):335-44. PubMed ID: 19180516
[TBL] [Abstract][Full Text] [Related]
13. Will Chinese external therapy with compound Tripterygium wilfordii hook F gel safely control disease activity in patients with rheumatoid arthritis: design of a double-blinded randomized controlled trial.
Jiang Q; Tang XP; Chen XC; Xiao H; Liu P; Jiao J
BMC Complement Altern Med; 2017 Sep; 17(1):444. PubMed ID: 28870177
[TBL] [Abstract][Full Text] [Related]
14. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.
Wang HL; Jiang Q; Feng XH; Zhang HD; Ge L; Luo CG; Gong X; Li B
BMC Complement Altern Med; 2016 Jul; 16():215. PubMed ID: 27411429
[TBL] [Abstract][Full Text] [Related]
15. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT
Arthritis Rheum; 2006 Jan; 54(1):26-37. PubMed ID: 16385520
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tripterygium wilfordii Hook F plus TNF inhibitor for active rheumatoid arthritis: A multicentre, randomized, double-blind, triple-dummy controlled trial.
Zhang X; Yang H; Zuo X; Wu L; Peng J; Li Z; Li H; Ji W; Zhang L; Li X; Dai L; Lu L; Yang N; Wei W; Shuai Z; Jiang Y; Liu Y; Lipsky PE; Chen H;
Clin Immunol; 2023 Oct; 255():109749. PubMed ID: 37657525
[TBL] [Abstract][Full Text] [Related]
17. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
[TBL] [Abstract][Full Text] [Related]
18. [The short-term efficacy and safety of methotrexate plus low dose prednisone in patients with rheumatoid arthritis].
Liu SY; Yang L; Zhang L; Zhang X; He YJ
Zhonghua Nei Ke Za Zhi; 2013 Dec; 52(12):1018-22. PubMed ID: 24503398
[TBL] [Abstract][Full Text] [Related]
19. A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.
Kremer JM; Cohen S; Wilkinson BE; Connell CA; French JL; Gomez-Reino J; Gruben D; Kanik KS; Krishnaswami S; Pascual-Ramos V; Wallenstein G; Zwillich SH
Arthritis Rheum; 2012 Apr; 64(4):970-81. PubMed ID: 22006202
[TBL] [Abstract][Full Text] [Related]
20. [Etanercept combined with Tripterygium wilfordii polyglycoside for treatment of rheumatoid arthritis in the elderly: a clinical study].
He WZ; Yin ZH; Gao JH; Ye ZZ; Xie Y; Kong WH; Chen YS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):267-71. PubMed ID: 24758073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
